- Home
- NLY vs SNN Comparison
NLY vs SNN Comparison
Compare NLY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLY
- SNN
- Stock Information
- Founded
- NLY 1996
- SNN 1856
- Country
- NLY United States
- SNN United Kingdom
- Employees
- NLY N/A
- SNN N/A
- Industry
- NLY Real Estate Investment Trusts
- SNN Industrial Specialties
- Sector
- NLY Real Estate
- SNN Health Care
- Exchange
- NLY Nasdaq
- SNN Nasdaq
- Market Cap
- NLY 12.6B
- SNN 11.4B
- IPO Year
- NLY 1997
- SNN 1999
- Fundamental
- Price
- NLY $19.28
- SNN $28.33
- Analyst Decision
- NLY Buy
- SNN Hold
- Analyst Count
- NLY 11
- SNN 3
- Target Price
- NLY $21.11
- SNN $27.50
- AVG Volume (30 Days)
- NLY 7.8M
- SNN 944.4K
- Earning Date
- NLY 04-30-2025
- SNN 02-25-2025
- Dividend Yield
- NLY 14.52%
- SNN 2.64%
- EPS Growth
- NLY N/A
- SNN 56.15
- EPS
- NLY 0.93
- SNN 0.47
- Revenue
- NLY $933,585,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- NLY $332.50
- SNN $6.39
- Revenue Next Year
- NLY $0.63
- SNN $5.11
- P/E Ratio
- NLY $20.62
- SNN $30.17
- Revenue Growth
- NLY N/A
- SNN 4.70
- 52 Week Low
- NLY $16.60
- SNN $23.65
- 52 Week High
- NLY $22.11
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- NLY 50.77
- SNN 60.78
- Support Level
- NLY $18.93
- SNN $28.02
- Resistance Level
- NLY $20.11
- SNN $28.71
- Average True Range (ATR)
- NLY 0.40
- SNN 0.42
- MACD
- NLY 0.14
- SNN 0.25
- Stochastic Oscillator
- NLY 69.37
- SNN 80.45
About NLY Annaly Capital Management Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.